Use of the CRUSADE bleeding risk score in the prediction of major bleeding for patients with acute coronary syndrome receiving enoxaparin in Thailand

Jinatongthai P 1 , Khaisombut N 2 , Likittanasombat K 3 , Chaiyakunapruk N 4 , Watcharathanakij S 1 , Nathisuwan S 5

Affiliations 

  • 1 Pharmacy Practice Division, Faculty of Pharmaceutical Sciences, Ubon Ratchathani University, Thailand
  • 2 Phayathai 3 Hospital, Bangkok, Thailand
  • 3 Divisions of Cardiology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Thailand
  • 4 School of Pharmacy, Monash University Malaysia, Selangor, Malaysia; Center of Pharmaceutical Outcomes Research (CPOR), Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand; School of Pharmacy, University of Wisconsin, Madison, USA; School of Population Health, University of Queensland, Brisbane, Australia
  • 5 Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Thailand. Electronic address: pysnt@mahidol.ac.th
Heart Lung Circ, 2014 Nov;23(11):1051-8.
PMID: 24931064 DOI: 10.1016/j.hlc.2014.05.002

Abstract

CRUSADE risk score stands out as a simple-to-use bleeding risk model. However, its use is still doubtful for Thai population. The aim of this study was to assess the prognostic value of CRUSADE in predicting risk of major bleeding among Thai patients with acute coronary syndrome (ACS) receiving enoxaparin.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications